Free Trial

54,521 Shares in Synopsys, Inc. (NASDAQ:SNPS) Purchased by Junto Capital Management LP

Synopsys logo with Computer and Technology background

Junto Capital Management LP acquired a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 54,521 shares of the semiconductor company's stock, valued at approximately $26,462,000.

Several other institutional investors have also modified their holdings of SNPS. Hudson Bay Capital Management LP lifted its position in Synopsys by 149.1% in the fourth quarter. Hudson Bay Capital Management LP now owns 42,008 shares of the semiconductor company's stock worth $20,389,000 after buying an additional 25,143 shares during the last quarter. Focus Partners Wealth lifted its holdings in shares of Synopsys by 60.7% in the 4th quarter. Focus Partners Wealth now owns 37,517 shares of the semiconductor company's stock worth $18,221,000 after acquiring an additional 14,167 shares during the last quarter. Fosun International Ltd purchased a new position in shares of Synopsys during the 4th quarter worth about $233,000. Ethic Inc. grew its holdings in Synopsys by 42.8% during the 4th quarter. Ethic Inc. now owns 16,610 shares of the semiconductor company's stock valued at $8,062,000 after purchasing an additional 4,982 shares during the last quarter. Finally, FORA Capital LLC purchased a new stake in Synopsys in the 4th quarter worth about $247,000. 85.47% of the stock is owned by institutional investors.

Synopsys Price Performance

Shares of NASDAQ SNPS opened at $482.69 on Friday. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $624.80. The business has a fifty day moving average price of $437.18 and a 200 day moving average price of $489.07. The stock has a market capitalization of $74.63 billion, a P/E ratio of 33.24, a price-to-earnings-growth ratio of 3.23 and a beta of 1.16.

Analyst Ratings Changes

SNPS has been the topic of a number of analyst reports. Needham & Company LLC reaffirmed a "buy" rating and set a $650.00 target price on shares of Synopsys in a research note on Thursday, February 27th. Piper Sandler reduced their target price on Synopsys from $655.00 to $653.00 and set an "overweight" rating on the stock in a research note on Thursday, February 27th. Rosenblatt Securities reissued a "buy" rating and set a $660.00 target price on shares of Synopsys in a research note on Tuesday, February 25th. Morgan Stanley reduced their price target on shares of Synopsys from $625.00 to $590.00 and set an "overweight" rating on the stock in a research note on Monday, February 24th. Finally, Stifel Nicolaus set a $550.00 price objective on shares of Synopsys in a research report on Monday, April 28th. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $613.43.

View Our Latest Stock Analysis on SNPS

Insiders Place Their Bets

In related news, insider Geus Aart De sold 15,705 shares of the stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the completion of the sale, the insider now owns 116,671 shares of the company's stock, valued at $51,850,925.82. This represents a 11.86 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Sassine Ghazi sold 11,366 shares of Synopsys stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the completion of the transaction, the chief executive officer now directly owns 70,922 shares in the company, valued at $32,890,077.50. This represents a 13.81 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.62% of the stock is currently owned by corporate insiders.

Synopsys Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Featured Articles

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines